GI
REGN icon

Gradient Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Gradient Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-827
Closed -$516K – 480
2026
Q2 		$516K Sell
827
-19
-2% -$12.9K 0.01% 369
2026
Q1 		$654K Sell
846
-50
-6% -$38.3K 0.01% 331
2025
Q4 		$692K Buy
+896
New +$608K 0.01% 265
2024
Q3 		– Sell
-9
Closed -$9.46K – 1045
2024
Q2 		$9.46K Sell
9
-1
-10% -$969 ﹤0.01% 748
2024
Q1 		$9.63K Sell
10
-6
-38% -$5.71K ﹤0.01% 644
2023
Q4 		$14.1K Hold
16
– – ﹤0.01% 773
2023
Q3 		$13.2K Sell
16
-1
-6% -$786 ﹤0.01% 754
2023
Q2 		$12.2K Buy
17
+4
+31% +$3.08K ﹤0.01% 778
2023
Q1 		$10.7K Sell
13
-1
-7% -$754 ﹤0.01% 799
2022
Q4 		$10.1K Hold
14
– – ﹤0.01% 808
2022
Q3 		$10K Hold
14
– – ﹤0.01% 809
2022
Q2 		$8K Buy
14
+3
+27% +$1.95K ﹤0.01% 826
2022
Q1 		$8K Hold
11
– – ﹤0.01% 827
2021
Q4 		$7K Hold
11
– – ﹤0.01% 878
2021
Q3 		$7K Hold
11
– – ﹤0.01% 839
2021
Q2 		$6K Hold
11
– – ﹤0.01% 854
2021
Q1 		$5K Sell
11
-1
-8% -$487 ﹤0.01% 892
2020
Q4 		$7K Hold
12
– – ﹤0.01% 761
2020
Q3 		$7K Buy
12
+5
+71% +$3.03K ﹤0.01% 768
2020
Q2 		$4K Buy
7
+1
+17% +$568 ﹤0.01% 791
2020
Q1 		$3K Hold
6
– – ﹤0.01% 870
2019
Q4 		$2K Buy
6
+2
+50% +$673 ﹤0.01% 954
2019
Q3 		$1K Buy
+4
New +$1.18K ﹤0.01% 1037
2018
Q2 		– Sell
-1
Closed – – 1111
2018
Q1 		$0 Sell
1
-3
-75% -$1.04K ﹤0.01% 1130
2017
Q4 		$2K Buy
+4
New +$1.62K ﹤0.01% 827
2015
Q3 		– Sell
-30
Closed -$15K – 668
2015
Q2 		$15K Buy
+30
New +$14.6K ﹤0.01% 337
2013
Q4 		– Sell
-2
Closed -$1K – 645
2013
Q3 		$1K Sell
2
-387
-99% -$102K ﹤0.01% 456
2013
Q2 		$87K Buy
+389
New +$90.6K 0.03% 153

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Gradient Investments's REGN Position: Q3 2026 in Review

Gradient Investments sold out of Regeneron Pharmaceuticals (REGN) in Q3 2026, closing a stake of 827 shares — an estimated $516K sold.

Gradient Investments first reported a position in REGN in Q2 2013 and held it in 28 quarters. The position peaked at $692K in Q4 2025. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Gradient Investments reported no remaining Regeneron Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Gradient Investments sold 827 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $516K.
  • Gradient Investments first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 28 quarters.
  • Gradient Investments's Regeneron Pharmaceuticals position peaked at $692K in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Gradient Investments's 13F filing for Q3 2026, filed 8 Oct 2026.